Back to Authors

Kubicka, Stefan

A5047515302 | I7877124

Mayo Clinic

Charité - Universitätsmedizin Berlin

Citations 4

Phase III trial of infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus capecitabine plus oxaliplatin (CAPOX) as first line treatment in advanced colorectal carcinoma (ACRC): Results of an interim safety analysis

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 3546-3546

10.1200/jco.2004.22.90140.3546

Infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus capecitabine plus oxaliplatin (CAPOX) as first line treatment of metastatic colorectal cancer (MCRC): Results of the safety and efficacy analysis

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 3507-3507

10.1200/jco.2005.23.16_suppl.3507

In Reply

Journal of Clinical Oncology | October 30, 2007 | Volume: 25 | Issue: 31 | Pages: 5042-5043

10.1200/jco.2007.14.4386

In Reply

Journal of Clinical Oncology | October 30, 2007 | Volume: 25 | Issue: 31 | Pages: 5045-5046

10.1200/jco.2007.13.4841